Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ro-CHOP vs CHOP in Untreated Peripheral T-cell Lymphoma
NCT01796002Phase 3Completed
- Sponsor
- LYSARC
- Start
- Jan 2013
- Primary completion
- Dec 2019
- Countries
- 8
01
Overview
Phase 3, randomised, open-label trial of romidepsin in peripheral T-cell lymphoma (PTCL), sponsored by LYSARC. Started Jan 2013; status: completed.
02
Drugs
romidepsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01796002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01796002.